Protocol of the development of a core outcome set for stroke in multidimensional value assessment of traditional Chinese medicine.

ABSTRACT:

Introduction

Stroke is the most common cause of death in China. In Chinese clinical practise, traditional Chinese medicine (TCM) and integrative medicine have been widely used as adjuvant therapies for the treatment of stroke. However, their clinical effectiveness, particularly their clinical value, has been inconsistent in the literature mainly because various outcome measures have been used and reported in clinical research. Hence, obtaining a comprehensive list of outcomes for TCM value assessment is crucial for a multidimensional value assessment. Therefore, the main objective of this protocol was to develop an outcome set used in health technology assessment (HTA) decision-making for TCM treatment of stroke.

Methods and analysis

The outcome set will be developed in four

SUBMITTER: Yuan J 

PROVIDER: S-EPMC10806626 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature